The LifeSphere® Platform
Powered by Nava
LifeSphere is an end-to-end life sciences platform, using ArisGlobal’s proprietary Nava® cognitive computing engine to automate all core functions of the drug development process. Offering simple integration with our next-generation LifeSphere EasyDocs document management solution across the product lifecycle, the LifeSphere platform helps life sciences companies reduce time to market, increase compliance and lower drug development costs.
LifeSphere®
Clinical Development
LifeSphere®
Regulatory
LifeSphere®
Safety
LifeSphere®
Medical Affairs
LifeSphere®
Quality
LifeSphere®
EasyDocs
seamlessly woven into the entire LifeSphere ecosystem.
The LifeSphere® Platform
Powered by Nava
LifeSphere is an end-to-end, cloud-based software platform, using ArisGlobal’s proprietary Nava® cognitive computing engine to automate all core functions of the drug development process. Offering simple integration with our next-generation LifeSphere EasyDocs document management solution across the product lifecycle, the LifeSphere platform helps life sciences companies reduce time to market, increase compliance and lower drug development costs.
LifeSphere®
Clinical Development
LifeSphere®
Regulatory
LifeSphere®
Safety
LifeSphere®
Medical Affairs
LifeSphere®
Quality
LifeSphere®
EasyDocs
Delivering Real Results to a Global Client Base
Delivering Real Results to a Global Client Base
80%
of the top 50 pharma companies are our clients
30%
immediate cost saving potential via our advance automation capabilities
80%
potential efficiency gains driven by our Nava cognitive computing engine.
100%
compliance with all present and upcoming regulatory standards.
LifeSphere MultiVigilance 10
Intelligent and Automated Safety Platform for Individual Case Safety Report Processing
Working with Some of the Industry’s Best
Working with Some of the Industry’s Best
What Our
Customers are Saying
“Our decision to upgrade to LifeSphere Safety MultiVigilance was based on better integration, improved case management, reduced costs, and the ability to reach even higher compliance requirements of our customers and regulators.”
Ravi Menon
Chairman of the Board,
APCER Life Sciences
“Advanced technology, such as artificial intelligence and machine learning, are key LSMV capabilities that help us automate repetitive, manual tasks, thus improving efficiency and compliance. By switching to LifeSphere Safety MultiVigilance, our efforts to comply with regulations will be much more efficient.”
Fosun Pharma
“We have seen how the LifeSphere platform’s advanced robotic automation and cognitive features will allow us to automate many of our key PV steps in the area of case processing, which are currently resource intensive”
Claudia Lehmann
Head of PV Operations,
Boehringer Ingelheim
News
Join Us At:
DIA Pharmacovigilance and Risk Management Strategies Conference
Jan 27 – 29, 2020 | Washington DC, US | Booth #24
Learn More
Join Us At:
Arab Health 2020
Jan 27 – 30, 2020 | Dubai, UAE | Booth #PZ.F31
Learn More
Join Us At:
DIA Regulatory Submissions,
Information and Document Management
February 10-12, 2020 | North Bethesda, MD, US | Booth #312
Learn More
Join Us At:
DIA Pharmacovigilance and Risk Management Strategies Conference
Jan 27 – 29, 2020 | Washington DC, US | Booth #24
Learn More
Join Us At:
Arab Health 2020
Jan 27 – 30, 2020 | Dubai, UAE | Booth #PZ.F31
Learn More
Join Us At:
DIA Regulatory Submissions,
Information and Document Management
February 10-12, 2020 | North Bethesda, MD, US | Booth #312
Learn More
Thought Leadership
Infographic
Global ICH E2B (R3) Implementation
Infographic
Global ICH E2B (R3) Implementation
The primary purpose of ICH E2B (R3) is to achieve consensus in safety reporting and harmonization of data for global electronic exchange. In reality, there might be several regional differences. Discover how and when 11 global Regulatory Authorities plan to implement ICH E2B (R3) standards.
